Raymond James & Associates Bio Rad Laboratories, Inc. Transaction History

Raymond James & Associates

  • $161 Billion
  • Q3 2024

A detailed history of Raymond James & Associates transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Raymond James & Associates holds 14,915 shares of BIO stock, worth $4.97 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,915
Previous 13,736 8.58%
Holding current value
$4.97 Million
Previous $3.75 Million 33.03%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024
BUY
$263.97 - $344.64 $311,220 - $406,330
1,179 Added 8.58%
14,915 $4.99 Million
Q2 2024

Jul 19, 2024
SELL
$268.26 - $339.48 $83,965 - $106,257
-313 Reduced 2.23%
13,736 $3.75 Million
Q1 2024

Apr 22, 2024
BUY
$304.11 - $351.99 $293,770 - $340,022
966 Added 7.38%
14,049 $4.86 Million
Q4 2023

Jan 16, 2024
SELL
$269.37 - $365.04 $5.83 Million - $7.9 Million
-21,649 Reduced 62.33%
13,083 $4.22 Million
Q3 2023

Oct 24, 2023
BUY
$350.25 - $422.63 $268,641 - $324,157
767 Added 2.26%
34,732 $12.4 Million
Q2 2023

Jul 25, 2023
BUY
$359.49 - $486.4 $1.6 Million - $2.16 Million
4,438 Added 15.03%
33,965 $12.9 Million
Q1 2023

Apr 14, 2023
BUY
$418.69 - $503.0 $681,208 - $818,381
1,627 Added 5.83%
29,527 $14.1 Million
Q4 2022

Feb 08, 2023
BUY
$351.71 - $456.01 $1.15 Million - $1.49 Million
3,278 Added 13.31%
27,900 $11.7 Million
Q3 2022

Oct 25, 2022
BUY
$412.59 - $563.26 $1.87 Million - $2.56 Million
4,540 Added 22.61%
24,622 $10.3 Million
Q2 2022

Aug 12, 2022
BUY
$463.67 - $597.16 $545,275 - $702,260
1,176 Added 6.22%
20,082 $9.94 Million
Q1 2022

May 11, 2022
SELL
$524.57 - $735.42 $1.4 Million - $1.96 Million
-2,665 Reduced 12.35%
18,906 $10.6 Million
Q4 2021

Feb 08, 2022
SELL
$708.84 - $794.68 $1.29 Million - $1.44 Million
-1,813 Reduced 7.75%
21,571 $16.3 Million
Q3 2021

Nov 02, 2021
SELL
$657.71 - $825.77 $2.74 Million - $3.44 Million
-4,168 Reduced 15.13%
23,384 $17.4 Million
Q2 2021

Aug 11, 2021
BUY
$576.64 - $649.04 $768,084 - $864,521
1,332 Added 5.08%
27,552 $17.8 Million
Q1 2021

May 14, 2021
BUY
$547.01 - $662.35 $2.87 Million - $3.47 Million
5,244 Added 25.0%
26,220 $15 Million
Q4 2020

Feb 12, 2021
BUY
$510.68 - $643.45 $3.59 Million - $4.52 Million
7,021 Added 50.31%
20,976 $12.2 Million
Q3 2020

Nov 04, 2020
BUY
$454.43 - $535.6 $1.43 Million - $1.69 Million
3,147 Added 29.12%
13,955 $7.19 Million
Q2 2020

Jul 28, 2020
BUY
$334.87 - $493.06 $351,613 - $517,713
1,050 Added 10.76%
10,808 $4.88 Million
Q1 2020

Apr 21, 2020
BUY
$320.01 - $409.07 $95,042 - $121,493
297 Added 3.14%
9,758 $3.42 Million
Q4 2019

Feb 12, 2020
BUY
$319.73 - $374.2 $45,721 - $53,510
143 Added 1.53%
9,461 $3.5 Million
Q3 2019

Nov 07, 2019
BUY
$304.55 - $345.24 $418,451 - $474,359
1,374 Added 17.3%
9,318 $3.1 Million
Q2 2019

Aug 06, 2019
BUY
$286.93 - $312.59 $25,536 - $27,820
89 Added 1.13%
7,944 $2.48 Million
Q1 2019

May 06, 2019
BUY
$224.3 - $317.41 $530,918 - $751,309
2,367 Added 43.13%
7,855 $2.4 Million
Q4 2018

Feb 11, 2019
SELL
$220.1 - $309.0 $180,261 - $253,071
-819 Reduced 12.99%
5,488 $1.27 Million
Q3 2018

Nov 14, 2018
SELL
$289.28 - $326.15 $225,927 - $254,723
-781 Reduced 11.02%
6,307 $1.97 Million
Q2 2018

Aug 14, 2018
SELL
$244.1 - $303.88 $366,638 - $456,427
-1,502 Reduced 17.49%
7,088 $2.05 Million
Q1 2018

May 14, 2018
BUY
$233.97 - $274.11 $4,913 - $5,756
21 Added 0.25%
8,590 $2.15 Million
Q4 2017

Feb 14, 2018
BUY
$216.94 - $271.3 $52,933 - $66,197
244 Added 2.93%
8,569 $2.05 Million
Q3 2017

Nov 13, 2017
SELL
$212.27 - $242.28 $4,245 - $4,845
-20 Reduced 0.24%
8,325 $1.85 Million
Q2 2017

Aug 14, 2017
BUY
N/A
8,345
8,345 $1.89 Million

Others Institutions Holding BIO

# of Institutions
457
Shares Held
18.2M
Call Options Held
19.5K
Put Options Held
13.9K
View Full List

About BIO-RAD LABORATORIES, INC.

BIO Quotes by TradingView
  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.2B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email